Finch Therapeutics Group Inc. Skyrocketed
Tue, Apr 16, 2024 at 07:16 PM
Finch Therapeutics Group Inc. (FNCH:NASDAQ) soared at $3.1, representing a gain of 39%. On Tue, Apr 16, 2024, FNCH:NASDAQ hit a New 2-Week High of $3.1. The stock appeared on our News Catalysts scanner on Tue, Mar 26, 2024 at 04:26 AM in the 'EARNINGS' category. From Tue, Apr 02, 2024, the stock recorded 30.00% Up Days and 45.45% Green Days
About Finch Therapeutics Group Inc. (FNCH:NASDAQ)
Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs.
Top 10 Gainers:
- Summit Wireless Technologies, Inc. (WISA:NASDAQ), 248.57%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 185.71%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Jaguar Health, Inc. (JAGX:NASDAQ), 50.08%
- Dynatronics Corporation (DYNT:NASDAQ), 48.25%
- StoneBridge Acquisition Corporation (APAC:NASDAQ), 43.03%
- Palisade Bio Inc. (PALI:NASDAQ), 42.55%
- Kineta Inc Com (KA:NASDAQ), 41.09%
- Finch Therapeutics Group Inc. (FNCH:NASDAQ), 39.01%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 38.89%